Okuda Osamu
Representative Director, President & CEO

We sincerely congratulate Health and Global Policy Institute (HGPI) on its 20th anniversary.

Since its founding in 1925, Chugai Pharmaceutical Co., Ltd. has been committed to contributing to global healthcare and human health through the research and development of innovative pharmaceuticals. After initiating a strategic alliance with the Swiss pharmaceutical company Roche in 2002, we have aimed to become a top innovator in the healthcare industry, realizing advanced and sustainable patient-centric healthcare. Under the three core values of “patient centric”, “pioneering spirit,” and “integrity,” we have been dedicated to creating innovative new drugs.

From its inception, we have supported HGPI’s noble philosophy and have been a supporting member since 2012. We have also participated in and cooperated with important projects such as “The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society” and “Patient and Public Involvement (PPI) Support Project”. In addition, we are grateful for the valuable opportunities provided by your organization, including dispatching our employees to the Health Policy Academy.

HGPI’s highly specialized policy recommendations have significantly contributed to improving Japan’s healthcare standards and solving challenges. Our company looks forward to HGPI’s continued activities toward the development of healthcare policies and the resolution of social issues in Japan. On this 20th anniversary milestone, we sincerely wish for HGPI’s further growth and success.

　■Company information
　Chugai Pharmaceutical Co., Ltd.
　https://www.chugai-pharm.co.jp/english/index.html